Form 4: West Pharmaceutical Services CEO Receives Stock Grant
Insider Transaction (Form 4)
Michel Lagarde, President and CEO and a Director of West Pharmaceutical Services Inc, reported multiple transactions in common stock on September 8, 2026.
Summary
- Grant/award: acquired 13,879 Stock Option (Right to Buy) on September 8, 2026; holds 13,879 after (Direct).
- Grant/award: acquired 11,081 Stock Option (Right to Buy) on September 8, 2026; holds 11,081 after (Direct).
- Grant/award: acquired 12,088 Stock Option (Right to Buy) on September 8, 2026; holds 12,088 after (Direct).
- Grant/award: acquired 6,200 Rst. Stock Unit on September 8, 2026; holds 6,200 after (Direct).
- Grant/award: acquired 4,950 Rst. Stock Unit on September 8, 2026; holds 4,950 after (Direct).
- Grant/award: acquired 3,600 Rst. Stock Unit on September 8, 2026; holds 3,600 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michel Lagarde — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Grant/award | Stock Option (Right to Buy) | 13,879 | — | — | 13,879 |
| 2026-09-08 | Grant/award | Stock Option (Right to Buy) | 11,081 | — | — | 11,081 |
| 2026-09-08 | Grant/award | Stock Option (Right to Buy) | 12,088 | — | — | 12,088 |
| 2026-09-08 | Grant/award | Rst. Stock Unit | 6,200 | — | — | 6,200 |
| 2026-09-08 | Grant/award | Rst. Stock Unit | 4,950 | — | — | 4,950 |
| 2026-09-08 | Grant/award | Rst. Stock Unit | 3,600 | — | — | 3,600 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Grant/award (13,879 shares) |
| 2026-09-08 | Grant/award (11,081 shares) |
| 2026-09-08 | Grant/award (12,088 shares) |
| 2026-09-08 | Grant/award (6,200 shares) |
| 2026-09-08 | Grant/award (4,950 shares) |
| 2026-09-08 | Grant/award (3,600 shares) |
Keywords
insider transaction, Form 4, WST, WEST PHARMACEUTICAL SERVICES INC, neutral, Michel Lagarde
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.